158 related articles for article (PubMed ID: 10822225)
41. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
42. Ovarian hilus-cell hyperplasia and high serum testosterone in a patient with postmenopausal virilization.
Delibasi T; Erdogan MF; Serinsöz E; Kaygusuz G; Erdogan G; Sertçelik A
Endocr Pract; 2007 Sep; 13(5):472-5. PubMed ID: 17872348
[TBL] [Abstract][Full Text] [Related]
43. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
Tng EL; Tan JM
Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
[TBL] [Abstract][Full Text] [Related]
44. Hyperandrogenism in post-menopausal women: a diagnosis challenge.
Tutzer M; Winnykamien I; Davila Guardia J; Castelo-Branco C
Gynecol Endocrinol; 2014 Jan; 30(1):23-5. PubMed ID: 24188447
[TBL] [Abstract][Full Text] [Related]
45. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
46. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary.
Krug E; Berga SL
Obstet Gynecol; 2002 May; 99(5 Pt 2):893-7. PubMed ID: 11975949
[TBL] [Abstract][Full Text] [Related]
47. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
48. A gonadotrophin dependent stromal luteoma: a rare cause of post-menopausal virilization.
Chico A; García JL; Matías-Guiu X; Webb SM; Rodríguez J; Prat J; Calaf J
Clin Endocrinol (Oxf); 1995 Nov; 43(5):645-9. PubMed ID: 8548951
[TBL] [Abstract][Full Text] [Related]
49. A case of postmenopausal androgen excess.
Lambrinoudaki I; Dafnios N; Kondi-Pafiti A; Triantafyllou N; Karopoulou E; Papageorgiou A; Augoulea A; Armeni E; Creatsa M; Vlahos N
Gynecol Endocrinol; 2015 Oct; 31(10):760-4. PubMed ID: 26287476
[TBL] [Abstract][Full Text] [Related]
50. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
Zhou WB; Chen N; Li CJ
BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
[TBL] [Abstract][Full Text] [Related]
51. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function.
Escobar-Morreale HF; Serrano-Gotarredona J; Avila S; Villar-Palasí J; Varela C; Sancho J
J Clin Endocrinol Metab; 1998 Jul; 83(7):2580-4. PubMed ID: 9661648
[TBL] [Abstract][Full Text] [Related]
52. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
Roth CL; Brendel L; Rückert C; Hartmann K
Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
[TBL] [Abstract][Full Text] [Related]
53. Cetrorelix suppression test in the diagnostic work-up of severe hyperandrogenism in adolescence.
de Man M; Derksen E; Pieters G; de Boer H
J Pediatr Endocrinol Metab; 2008 Sep; 21(9):905-9. PubMed ID: 18924583
[TBL] [Abstract][Full Text] [Related]
54. Use of gonadotropin-releasing hormone agonists in the treatment of hyperandrogenism.
Rittmaster RS
Clin Obstet Gynecol; 1993 Sep; 36(3):679-89. PubMed ID: 8403614
[No Abstract] [Full Text] [Related]
55. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
White D; Leigh A; Wilson C; Donaldson A; Franks S
Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
[TBL] [Abstract][Full Text] [Related]
56. Direct in-vivo detection of atypical hormonal expression of a Sertoli-Leydig cell tumour following stimulation with human chorionic gonadotrophin.
Cohen I; Shapira M; Cuperman S; Goldberger S; Siegal A; Altaras M; Beyth Y
Clin Endocrinol (Oxf); 1993 Oct; 39(4):491-5. PubMed ID: 8287578
[TBL] [Abstract][Full Text] [Related]
57. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
[TBL] [Abstract][Full Text] [Related]
58. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
[TBL] [Abstract][Full Text] [Related]
59. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report.
Wu DH; McMurtrie DG; Hirsch SD; Johnston CM
J Reprod Med; 2008 Feb; 53(2):141-4. PubMed ID: 18357809
[TBL] [Abstract][Full Text] [Related]
60. [The ovarian origin of hiperandrogenism in the postmenopausal woman the adrenal adenoma--a case report].
Mrozińska S; Kiałka M; Doroszewska K; Milewicz T; Jach R
Przegl Lek; 2015; 72(7):387-90. PubMed ID: 26817354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]